SAFETY PROFILE OF BARICITINIB IN PATIENTS WITH ACTIVE RA: AN INTEGRATED ANALYSIS

被引：15
|
作者：
Smolen, J. [1 ]
Genovese, M. [2 ]
Takeuchi, T. [3 ]
Hyslop, D.
Macias, W. L. [4 ]
Rooney, T. P. [4 ]
Chen, L. [4 ]
Dickson, C. [4 ]
Riddle, J. [4 ]
Cardillo, T. [4 ]
Winthrop, K. [5 ]
机构：
[1] Med Univ Vienna, Vienna, Austria
[2] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA
[3] Keio Univ, Tokyo, Japan
[4] Eli Lilly & Co, Indianapolis, IN 46285 USA
[5] Oregon Hlth & Sci Univ, Portland, OR USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.1612
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0166
引用
收藏
页码：243 / 244
页数：2
相关论文
共 50 条
  • [21] SAFETY PROFILE OF BARICITINIB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS UP TO 7 YEARS: AN UPDATED INTEGRATED SAFETY ANALYSIS
    Genovese, Mark C.
    Smolen, Josef S.
    Takeuchi, Tsutomu
    Burmester, Gerd Ruediger
    Brinker, Dennis
    Rooney, Terence
    Zhong, Jinglin
    Mo, Daojun
    Saifan, Chadi
    Cardoso, Anabela
    Issa, Maher
    Wu, Wen-Shuo
    Winthrop, Kevin
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 308 - 309
  • [22] SAFETY PROFILE OF BARICITINIB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS UP TO 7 YEARS: AN UPDATED INTEGRATED SAFETY ANALYSIS
    Hall, Stephen
    Genovese, Mark C.
    Smolen, Josef S.
    Takeuchi, Tsutomu
    Burmester, Gerd
    Brinker, Dennis
    Rooney, Terence P.
    Zhong, Jinglin
    Mo, Daojun
    Saifan, Chadi
    Cardoso, Anabela
    Issa, Maher
    Wu, Wen-Shuo
    Winthrop, Kevin L.
    INTERNAL MEDICINE JOURNAL, 2020, 50 : 16 - 16
  • [23] Safety Profile of Baricitinib for the Treatment of Rheumatoid Arthritis up to 5.5 Years: An Updated Integrated Safety Analysis
    Keystone, Edward
    Genovese, Mark
    Smolen, Josef
    Takeuchi, Tsutomu
    Hyslop, David
    Macias, William
    Rooney, Terence
    Chen, Lei
    Dickson, Christina
    Camp, Jennifer
    Cardillo, Tracy
    Ishii, Taeko
    Winthrop, Kevin
    Otawa, Susan
    JOURNAL OF RHEUMATOLOGY, 2018, 45 (07) : 1003 - 1003
  • [24] Safety Profile of Baricitinib for the Treatment of Rheumatoid Arthritis up to 6 Years: An Updated Integrated Safety Analysis
    Keystone, Edward
    Genovese, Mark
    Smolen, Josef
    Takeuchi, Tsutomu
    Rooney, Terence
    Dickson, Christina
    Saifan, Chadi
    Cardoso, Anabela
    Issa, Maher
    Ishii, Taeko
    Winthrop, Kevin
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (07) : 804 - 805
  • [25] Safety profile of baricitinib in Japanese patients with active rheumatoid arthritis with over 1.6 years median time in treatment: An integrated analysis of Phases 2 and 3 trials
    Harigai, Masayoshi
    Takeuchi, Tsutomu
    Smolen, Josef S.
    Winthrop, Kevin L.
    Nishikawa, Atsushi
    Rooney, Terence P.
    Saifan, Chadi G.
    Issa, Maher
    Isaka, Yoshitaka
    Akashi, Naotsugu
    Ishii, Taeko
    Tanaka, Yoshiya
    MODERN RHEUMATOLOGY, 2020, 30 (01) : 36 - 43
  • [26] Safety profile of baricitinib for the treatment of rheumatoid arthritis over a median of 3 years of treatment: an updated integrated safety analysis
    Genovese, Mark C.
    Smolen, Josef S.
    Takeuchi, Tsutomu
    Burmester, Gerd
    Brinker, Dennis
    Rooney, Terence P.
    Zhong, Jinglin
    Mo Daojun
    Saifan, Chadi
    Cardoso, Anabela
    Issa, Maher
    Wu, Wen-Shuo
    Winthrop, Kevin L.
    LANCET RHEUMATOLOGY, 2020, 2 (06): : E347 - E357
  • [27] Safety Profile of Baricitinib in Patients with Active Rheumatoid Arthritis with over 2 Years Median Time in Treatment
    Smolen, Josef S.
    Genovese, Mark C.
    Takeuchi, Tsutomu
    Hyslop, David L.
    Macias, William L.
    Rooney, Terence
    Chen, Lei
    Dickson, Christina L.
    Camp, Jennifer Riddle
    Cardillo, Tracy E.
    Ishii, Taeko
    Winthrop, Kevin L.
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (01) : 7 - 18
  • [28] Safety of baricitinib in East Asian patients with moderate-to-severe active rheumatoid arthritis: An integrated analysis from clinical trials
    Chen, Ying-Chou
    Yoo, Dae Hyun
    Lee, Chang Keun
    Li, Ko-Jen
    Won, Ji-Eon
    Wu, Wen-Shuo
    Zhong, Jinglin
    Nicolay, Claudia
    Walls, Chad Daniel
    Tanaka, Yoshiya
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2020, 23 (01) : 65 - 73
  • [29] Safety profile of anifrolumab in patients with active SLE: an integrated analysis of phase II and III trials
    Tummala, Raj
    Abreu, Gabriel
    Pineda, Lilia
    Michaels, M. Alex
    Kalyani, Rubana N.
    Furie, Richard A.
    Morand, Eric F.
    LUPUS SCIENCE & MEDICINE, 2021, 8 (01):
  • [30] THROMBOEMBOLIC SAFETY PROFILE OF TOFACITINIB AND BARICITINIB: AN ANALYSIS OF WHO VIGIBASE
    Vallejo-Yague, E.
    Weiler, S.
    Burden, A. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 150 - 150
12345